Effects of Dexamethasone on Common Bile Duct Cannulation Time
Can Deep Common Bile Duct Cannulation Time During Endoscopic Retrograde Cholangiopancreatography Be Shortened by Dexamethasone
Can Deep Common Bile Duct Cannulation Time During Endoscopic Retrograde Cholangiopancreatography Be Shortened by Dexamethasone
Sponsor study identifier
interventional
80
1 country
1
Study Start
August 1, 2023
Actual (reported)Primary Completion
April 12, 2024
Actual (reported)Study Completion
May 16, 2024
Actual (reported)The main aim of this clinical trial is to evaluate the effects of dexamethasone on common bile duct cannulation time during endoscopic retrograde cholangiopancreatography (ERCP) in patients with biliary pathologies. The study will also study the effects of dexamethasone on total procedure time and total fluoroscopy time during ERCP. Participants will be divided into two groups, treatment group and placebo group. Patients in treatment group will receive dexamethasone and those in placebo group will be given normal saline before undergoing ERCP. The results in both groups will be compared to determine the effects of dexamethasone.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 16, 2024
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 11, 2023
Actual (reported)July 14, 2023
Actual (reported)August 1, 2023
Actual (reported)April 12, 2024
Actual (reported)May 16, 2024
Actual (reported)Shortening of CBD cannulation time
To determine the effects of dexamethasone on shortening of CBD cannulation time
CBD cannulation time will be calculated from the start of the procedure (0 minutes) till complete CBD cannulation has been achieved through catheter and confirmed by fluoroscopy or procedure abandoned if unsuccessful cannulation by 30 minutes.
Experimental arm patients will be receiving 2 ml (4mg) of dexamenthasone prior to undergoing ERCP.
Placebo arm patients will be receiving 2 ml of normal saline prior to undergoing ERCP.
An injection of 4mg of dexamethasone will be given to patients approximately 2 to 4 hours prior to the procedure of ERCP.
Gujranwala Medical College Hospital
Gujranwala, Punjab Province, 52070, Pakistan
Sherman S, Lehman GA. Endoscopic retrograde cholangiopancreatography, endoscopic sphincterotomy and stone removal, and endoscopic biliary and pancreatic drainage. In: Yamada T, et al. (eds.) Text book of gastroenterology. 3rd edn. Philadelphia: Lippincott, Williams & Wilkins ; 1999: 2718 - 2746
Wehrmann T, Schmitt T, Stergiou N, Caspary WF, Seifert H. Topical application of nitrates onto the papilla of Vater: manometric and clinical results. Endoscopy. 2001 Apr;33(4):323-8. doi: 10.1055/s-2001-13687.
Allescher HD, Neuhaus H, Hagenmuller F, Classen M. Effect of N-butylscopolamine on sphincter of Oddi motility in patients during routine ERCP--a manometric study. Endoscopy. 1990 Jul;22(4):160-3. doi: 10.1055/s-2007-1012829.
Najam us Sehar Saeed, FCPS-Gastro
GMC-DHQ Hospital, Gujwanala, Pakistan
80 participants (actual enrollment reported by the registry).
First Submitted
June 11, 2023
First Posted
July 14, 2023
Study Start
August 1, 2023
Actual (reported)Contact the study team to confirm eligibility.
Sola-Bonada N, de Andres-Lazaro AM, Roca-Massa M, Bordas-Alsina JM, Codina-Jane C, Ribas-Sala J. [1.6% peppermint oil solution as intestinal spasmolytic in retrograde endoscopic cholangiopancreatography]. Farm Hosp. 2012 Jul-Aug;36(4):256-60. doi: 10.1016/j.farma.2011.08.003. Epub 2011 Dec 1. Spanish.
Devereaux BM, Lehman GA, Fein S, Phillips S, Fogel EL, Sherman S. Facilitation of pancreatic duct cannulation using a new synthetic porcine secretin. Am J Gastroenterol. 2002 Sep;97(9):2279-81. doi: 10.1111/j.1572-0241.2002.05982.x.
Primary Completion
April 12, 2024
Actual (reported)Study Completion
May 16, 2024
Actual (reported)Last Updated
March 21, 2025
Record last verified: 2025-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: